Leonteq Securities AG’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$25.4K 1357
2022
Q3
$25.4K Hold
1,000
﹤0.01% 925
2022
Q2
$33.2K Buy
+1,000
New +$42.5K ﹤0.01% 902
2022
Q1
Sell
-500
Closed -$45.9K 1332
2021
Q4
$45.9K Buy
+500
New +$59.8K ﹤0.01% 916
2021
Q2
Sell
-100
Closed -$18.2K 1125
2021
Q1
$18.2K Buy
+100
New +$23.2K ﹤0.01% 899

Other funds holding TDOC

Leonteq Securities AG's TDOC Position: Q2 2026 in Review

Leonteq Securities AG increased its Teladoc Health (TDOC) stake by 13% in Q2 2026, buying an estimated $97.6K and bringing the position to 125,517 shares worth $1.06M. The position accounts for 0.04% of the portfolio, ranked #256.

Leonteq Securities AG first reported a position in TDOC in Q4 2020 and has held it in 23 quarters since. The position peaked at $13.6M in Q4 2021. 344 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Leonteq Securities AG held 125,517 shares of Teladoc Health worth $1.06M as of Q2 2026.
  • Leonteq Securities AG bought 14,670 Teladoc Health shares in Q2 2026, an estimated $97.6K.
  • Teladoc Health made up 0.04% of Leonteq Securities AG's portfolio in Q2 2026, its #256 holding.
  • Leonteq Securities AG first reported a position in Teladoc Health in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Teladoc Health position peaked at $13.6M in Q4 2021.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.